As obesity rates in the United States have reached 41.9 percent among adults, Xevant has released a new e-book, Navigating Obesity Care and GLP-1 Coverage: A Guide for Employers, designed to empower ...

A new weight loss service offering GLP-1 injections has been launched. Vertis Health, based in Worcestershire, has introduced the service through its Well by Vertis programme. This comes as a response ...

Patients with overweight or obesity who used maridebart cafraglutide experienced significant weight loss at 1 year, according ...

One in eight people living in the United States has taken a GLP-1 medication — such as Ozempic, Mounjaro, or Zepbound — for ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

The New Year is a time of reflection and change for many Americans, who start each January with a clean slate and goals for ...

Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...

People lose weight via three primary methods: diet and exercise, weight loss surgery and GLP-1 weight loss drugs. The ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

A new weight loss service offering GLP-1 injections has been launched. Vertis Health, based in Worcestershire, has introduced the service through its Well by Vertis programme. This comes as a ...